|
Completed
|
NCT05471336 -
Enteral Feeding and Splanchnic NIRS Values in Infants With Neonatal Encephalopathy (NE)
|
N/A |
|
Recruiting
|
NCT05514340 -
Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy
|
Phase 2 |
|
Recruiting
|
NCT04603547 -
Transcutaneous Carbon Dioxide Monitoring in Neonates Receiving Therapeutic Hypothermia for Neonatal Encephalopathy
|
|
|
Completed
|
NCT01913340 -
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
|
Phase 1/Phase 2 |
|
Completed
|
NCT00581581 -
CoolCap Followup Study-Coordination of Participating Centers
|
N/A |
|
Completed
|
NCT03122808 -
Uterine Activity in Moderate-Severe Neonatal Encephalopathy: A Case Control Study
|
|
|
Recruiting
|
NCT02544100 -
Neonatal Neurologic Intensive Care Network of China
|
|
|
Completed
|
NCT03380013 -
OMT to Improve Feeding After Hypothermia
|
N/A |
|
Active, not recruiting
|
NCT03409770 -
Optimising the Duration of Cooling in Mild Encephalopathy
|
N/A |
|
Recruiting
|
NCT05127070 -
Evaluating the NeoTree in Malawi and Zimbabwe
|
|
|
Not yet recruiting
|
NCT06098833 -
Treatment of Neonatal Encephalopathy With Oral Sildenafil Suspension to Repair Brain Injury Secondary to Birth Asphyxia
|
Phase 2 |
|
Not yet recruiting
|
NCT05756296 -
The Long-term Consequences of Neonatal Encephalopathy in the Hypothermia Era
|
|
|
Recruiting
|
NCT04432662 -
Darbepoetin in Neonatal Encephalopathy Trial
|
Phase 2 |
|
Recruiting
|
NCT02793999 -
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
|
|
|
Not yet recruiting
|
NCT05889507 -
Cooling in Mild Encephalopathy
|
N/A |
|
Recruiting
|
NCT05848271 -
Natural History Study of Patients With HPDL Mutations
|
|
|
Not yet recruiting
|
NCT04176471 -
TIME Study: Therapeutic Hypothermia for Infants With Mild Encephalopathy
|
N/A |
|
Completed
|
NCT01309711 -
Magnetic Resonance Biomarkers in Neonatal Encephalopathy
|
|
|
Recruiting
|
NCT04225975 -
Neonate Cerebral Activity in Immediate Post Partum
|
N/A |
|
Recruiting
|
NCT05610085 -
A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
|
Phase 2 |